Structure Overhaul Affords a Potent Purine PI3Kδ Inhibitor with Improved Tolerability. [electronic resource]
- Journal of medicinal chemistry 05 2019
- 4370-4382 p. digital
Publication Type: Journal Article
1520-4804
10.1021/acs.jmedchem.8b01818 doi
Animals Class Ia Phosphatidylinositol 3-Kinase--metabolism Dogs Drug Design HeLa Cells Humans Male Protein Kinase Inhibitors--chemical synthesis Purines--chemical synthesis Pyrrolidines--chemical synthesis Rats, Wistar